Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma

Junchao Guo, Jörg Kleeff, Junsheng Li, Jiayi Ding, Jürgen Hammer, Yupei Zhao, Thomas Giese, Murray Korc, Markus W. Büchler, Helmut Friess

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related deaths. Deregulation of cell-cycle control is thought to be a crucial event in malignant transformation, and CDC25 phosphatases are a family of cyclin-dependent kinase activators, which act at different points of the cell cycle, including G1-S and G2-M transition. Here, we investigated the expression and functional significance of CDC25s in PDAC. CDC25B mRNA expression levels in human pancreatic tissue samples were analysed by cDNA array, quantitative PCR and Northern blotting. Immunohistochemistry was carried out to localize and quantify CDC25B expression. Two specific CDC25B inhibitors were utilized to determine the functional relevance of CDC25B. By quantitative RT-PCR, CDC25B mRNA was overexpressed in pancreatic cancer (7.5-fold) in comparison to the normal pancreas. Strong nuclear CDC25B immunoreactivity was present in both pancreatic and metastatic cancer samples, and there was a marked increase of the percentage of positive cells in primary cancer (48.6 ± 16.3%) and metastatic tissues (71.7 ± 3.1%) compared to normal samples (8.3 ± 1.8%). Two CDC25B inhibitors reduced the growth of pancreatic cancer cell lines, resulting in the accumulation of phosphorylated CDC2 and G2/M arrest. These findings demonstrate an important role of CDC25B in cell-cycle progression, raising the possibility that inhibition of CDC25B may have therapeutic potential in pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)71-81
Number of pages11
JournalOncogene
Volume23
Issue number1
DOIs
StatePublished - Jan 8 2004
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Adenocarcinoma
Cell Cycle
Polymerase Chain Reaction
Growth Inhibitors
Messenger RNA
Cyclin-Dependent Kinases
Cell Cycle Checkpoints
Oligonucleotide Array Sequence Analysis
Phosphoric Monoester Hydrolases
Northern Blotting
Pancreas
Neoplasms
Immunohistochemistry
Cell Line
Therapeutics

Keywords

  • CDC25B
  • Cell cycle
  • Cyclin-dependent kinase
  • Pancreatic ductal adenocarcinoma

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Guo, J., Kleeff, J., Li, J., Ding, J., Hammer, J., Zhao, Y., ... Friess, H. (2004). Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma. Oncogene, 23(1), 71-81. https://doi.org/10.1038/sj.onc.1206926

Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma. / Guo, Junchao; Kleeff, Jörg; Li, Junsheng; Ding, Jiayi; Hammer, Jürgen; Zhao, Yupei; Giese, Thomas; Korc, Murray; Büchler, Markus W.; Friess, Helmut.

In: Oncogene, Vol. 23, No. 1, 08.01.2004, p. 71-81.

Research output: Contribution to journalArticle

Guo, J, Kleeff, J, Li, J, Ding, J, Hammer, J, Zhao, Y, Giese, T, Korc, M, Büchler, MW & Friess, H 2004, 'Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma', Oncogene, vol. 23, no. 1, pp. 71-81. https://doi.org/10.1038/sj.onc.1206926
Guo, Junchao ; Kleeff, Jörg ; Li, Junsheng ; Ding, Jiayi ; Hammer, Jürgen ; Zhao, Yupei ; Giese, Thomas ; Korc, Murray ; Büchler, Markus W. ; Friess, Helmut. / Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma. In: Oncogene. 2004 ; Vol. 23, No. 1. pp. 71-81.
@article{b964d338a6864ca3b9ec4ea9231107cb,
title = "Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma",
abstract = "Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related deaths. Deregulation of cell-cycle control is thought to be a crucial event in malignant transformation, and CDC25 phosphatases are a family of cyclin-dependent kinase activators, which act at different points of the cell cycle, including G1-S and G2-M transition. Here, we investigated the expression and functional significance of CDC25s in PDAC. CDC25B mRNA expression levels in human pancreatic tissue samples were analysed by cDNA array, quantitative PCR and Northern blotting. Immunohistochemistry was carried out to localize and quantify CDC25B expression. Two specific CDC25B inhibitors were utilized to determine the functional relevance of CDC25B. By quantitative RT-PCR, CDC25B mRNA was overexpressed in pancreatic cancer (7.5-fold) in comparison to the normal pancreas. Strong nuclear CDC25B immunoreactivity was present in both pancreatic and metastatic cancer samples, and there was a marked increase of the percentage of positive cells in primary cancer (48.6 ± 16.3{\%}) and metastatic tissues (71.7 ± 3.1{\%}) compared to normal samples (8.3 ± 1.8{\%}). Two CDC25B inhibitors reduced the growth of pancreatic cancer cell lines, resulting in the accumulation of phosphorylated CDC2 and G2/M arrest. These findings demonstrate an important role of CDC25B in cell-cycle progression, raising the possibility that inhibition of CDC25B may have therapeutic potential in pancreatic cancer.",
keywords = "CDC25B, Cell cycle, Cyclin-dependent kinase, Pancreatic ductal adenocarcinoma",
author = "Junchao Guo and J{\"o}rg Kleeff and Junsheng Li and Jiayi Ding and J{\"u}rgen Hammer and Yupei Zhao and Thomas Giese and Murray Korc and B{\"u}chler, {Markus W.} and Helmut Friess",
year = "2004",
month = "1",
day = "8",
doi = "10.1038/sj.onc.1206926",
language = "English (US)",
volume = "23",
pages = "71--81",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma

AU - Guo, Junchao

AU - Kleeff, Jörg

AU - Li, Junsheng

AU - Ding, Jiayi

AU - Hammer, Jürgen

AU - Zhao, Yupei

AU - Giese, Thomas

AU - Korc, Murray

AU - Büchler, Markus W.

AU - Friess, Helmut

PY - 2004/1/8

Y1 - 2004/1/8

N2 - Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related deaths. Deregulation of cell-cycle control is thought to be a crucial event in malignant transformation, and CDC25 phosphatases are a family of cyclin-dependent kinase activators, which act at different points of the cell cycle, including G1-S and G2-M transition. Here, we investigated the expression and functional significance of CDC25s in PDAC. CDC25B mRNA expression levels in human pancreatic tissue samples were analysed by cDNA array, quantitative PCR and Northern blotting. Immunohistochemistry was carried out to localize and quantify CDC25B expression. Two specific CDC25B inhibitors were utilized to determine the functional relevance of CDC25B. By quantitative RT-PCR, CDC25B mRNA was overexpressed in pancreatic cancer (7.5-fold) in comparison to the normal pancreas. Strong nuclear CDC25B immunoreactivity was present in both pancreatic and metastatic cancer samples, and there was a marked increase of the percentage of positive cells in primary cancer (48.6 ± 16.3%) and metastatic tissues (71.7 ± 3.1%) compared to normal samples (8.3 ± 1.8%). Two CDC25B inhibitors reduced the growth of pancreatic cancer cell lines, resulting in the accumulation of phosphorylated CDC2 and G2/M arrest. These findings demonstrate an important role of CDC25B in cell-cycle progression, raising the possibility that inhibition of CDC25B may have therapeutic potential in pancreatic cancer.

AB - Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related deaths. Deregulation of cell-cycle control is thought to be a crucial event in malignant transformation, and CDC25 phosphatases are a family of cyclin-dependent kinase activators, which act at different points of the cell cycle, including G1-S and G2-M transition. Here, we investigated the expression and functional significance of CDC25s in PDAC. CDC25B mRNA expression levels in human pancreatic tissue samples were analysed by cDNA array, quantitative PCR and Northern blotting. Immunohistochemistry was carried out to localize and quantify CDC25B expression. Two specific CDC25B inhibitors were utilized to determine the functional relevance of CDC25B. By quantitative RT-PCR, CDC25B mRNA was overexpressed in pancreatic cancer (7.5-fold) in comparison to the normal pancreas. Strong nuclear CDC25B immunoreactivity was present in both pancreatic and metastatic cancer samples, and there was a marked increase of the percentage of positive cells in primary cancer (48.6 ± 16.3%) and metastatic tissues (71.7 ± 3.1%) compared to normal samples (8.3 ± 1.8%). Two CDC25B inhibitors reduced the growth of pancreatic cancer cell lines, resulting in the accumulation of phosphorylated CDC2 and G2/M arrest. These findings demonstrate an important role of CDC25B in cell-cycle progression, raising the possibility that inhibition of CDC25B may have therapeutic potential in pancreatic cancer.

KW - CDC25B

KW - Cell cycle

KW - Cyclin-dependent kinase

KW - Pancreatic ductal adenocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=9144240387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144240387&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1206926

DO - 10.1038/sj.onc.1206926

M3 - Article

VL - 23

SP - 71

EP - 81

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 1

ER -